PRO PHARMACEUTICALS INC
BalancedPRW·US·🇺🇸 US
53%buys·47%sales
1,529 transactions$64.7MTotal buys·307 buys
$48.6MTotal sells·271 sells
4040 insiders
Last: Dec 23, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 23, 25 | ELDRED KARY | Buy | $3K | |
| Dec 23, 25 | FREEMAN KEVIN D | Buy | $20K | |
| Dec 23, 25 | ELDRED KARY | Buy | $3K | |
| Dec 23, 25 | FREEMAN KEVIN D | Buy | $20K | |
| Dec 23, 25 | FREEMAN KEVIN D | Buy | $20K | |
| Dec 17, 25 | Shlevin Harold H. | Exercise | - | |
| Dec 17, 25 | Jamil Khurram | Exercise | - | |
| Dec 17, 25 | Jamil Khurram | Exercise | - | |
| Dec 17, 25 | LEWIS JOEL | Exercise | - | |
| Dec 17, 25 | Shlevin Harold H. | Sell | $139K |
Shlevin Harold H. (CEO) recently executed a sell of $139K in PRO PHARMACEUTICALS INC shares on December 17, 2025. Insider activity shows a balanced mix of buying and selling.
PRO PHARMACEUTICALS INC (PRW) has recorded 1 529 insider operations, including 307 open-market purchases ($64.7M), 271 sales ($48.6M) and 951 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Insider activity at PRO PHARMACEUTICALS INC is sustained, with operations recorded in 10 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are LEWIS JOEL (CEO), Shlevin Harold H. (CEO) & PLATT DAVID (CEO), with respectively 129, 96, 94 transactions.
Across all 1 529 recorded transactions, the breakdown by type is: exercise (386, 25%), grant (366, 24%), buys (307, 20%), sales (271, 18%), other (134, 9%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
PRO PHARMACEUTICALS INC has recorded 1 529 insider operations in total, including 307 open-market purchases ($64.7M), 271 sales ($48.6M) and 951 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 23, 2025.
Insiders at PRO PHARMACEUTICALS INC show balanced activity with 53% purchases and 47% sales. Total buy volume is $64.7M versus $48.6M in sales.
InsiderLens tracks 40 insiders at PRO PHARMACEUTICALS INC (PRW). LEWIS JOEL (CEO, 129 tx), Shlevin Harold H. (CEO, 96 tx), PLATT DAVID (CEO, 94 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for PRW is neutral, based on a 53% buy ratio across 578 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for PRO PHARMACEUTICALS INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.